CBUS
$3.68
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the...
Recent News
Mission Produce, Inc. (AVO) Surpasses Q1 Earnings Estimates
Mission Produce (AVO) delivered earnings and revenue surprises of +42.86% and -7.90%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders
Key Insights Significant control over Cibus by individual investors implies that the general public has more power to...
Cibus Inc (CBUS) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges
Despite a dip in revenue, Cibus Inc (CBUS) makes significant strides in regulatory approvals, board strengthening, and cost management, setting the stage for future growth.
Cibus: Q3 Earnings Snapshot
SAN DIEGO (AP) — Cibus, Inc. CBUS) on Thursday reported a loss of $23.5 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of 44 cents.
Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates
Bioceres Crop (BIOX) delivered earnings and revenue surprises of -200.00% and -18.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?